Discover Firefly Neuroscience’s journey from pioneering research to groundbreaking advancements in brain health assessments.
Amidst a dynamic global innovation landscape, Firefly Neuroscience embarked on an ambitious journey with a singular goal: to revolutionize the way we understand and address cognitive disorders.
Firefly has curated the industry’s most comprehensive standardized EEG brain recording database focusing on Event-Related Potentials (ERPs) and longitudinal data. Our efforts have been recognized and validated through significant regulatory milestones, including FDA Class II medical device 510(k) clearance and CE mark approval, amplifying our impact globally.
Brain Network Analytics (BNA™) empowers healthcare providers with unparalleled insights into brain function – facilitating precise assessments and tailored treatment plans for traumatic brain injuries like concussions and cognitive disorders such as Alzheimer’s or Parkinson’s disease.
Firefly is not merely navigating the present; we’re illuminating a clearer path to a future where brain health is understood and accessible.
Through AI, we innovatively harness the power of data to amplify clinical insight and enable greater precision in neurological care.
To redefine the standard of care for those navigating cognitive disorders.
To consistently achieve responsible clinical-grade innovation, we uphold three grounding values, while embracing three that propel our forward-thinking:
We prioritize the trust and security of our colleagues, customers and patients — upholding ethical standards and ensuring our initiatives follow industry regulations including privacy guidelines and data protection measures.
We believe in taking ownership of our actions, decisions, and outcomes. By fostering a culture focused on patient-centricity and responsibility, we honor our commitments to our teammates and customers, building trust and setting the standard for excellence.
Our elevated, clinical-grade standards and meticulous attention to detail are the cornerstone of our success, fostering a sense of passion, purpose and pride in our work.
We’re data-driven, not opinion-led, and we believe operating this way creates an inclusive environment where all stakeholders can collaborate with confidence and be bold and courageous in driving advancements.
We’re dedicated to building and deploying groundbreaking solutions that are purpose-built to redefine the standard of care and empower those navigating brain health conditions with a clearer path to improved outcomes.
We have an unwavering commitment to creating and positively responding to change–bringing an openness to fresh ideas, having a willingness to explore new possibilities and an eagerness to test and learn in an ever-evolving environment.
Discover the dedicated team of experts leading Firefly Neuroscience to the forefront of brain health technology.
LEARN MORE
At Firefly Neuroscience, our dedication to advancing brain health technology is evident in every aspect of our work. By aggregating and analyzing vast datasets, we’ve created BNA™ (Brain Network Analytics) to provide healthcare professionals and patients with deep insights into brain function that can enable more accurate assessments and personalized treatment plans.
We’re on a mission to transform neurological care, and we need passionate individuals to join us. If you’re driven to make a real impact and thrive in a dynamic environment, explore our openings and be part of shaping the future of healthcare.
LEARN MORE
Contact Firefly Neuroscience to learn more about BNA™ or schedule a product demo. We’re here to assist and provide you with the information you need to make the best decision for your practice.
Firefly Neuroscience is a pioneering company specializing in AI-powered brain assessments for neurological disorders. Our flagship product, Brain Network Analytics (BNA™), utilizes artificial intelligence to analyze brain waves and can enable early detection of subtle neurological deviations, facilitating personalized care plans and enhancing outcomes.
BNA™ is an advanced technology developed by Firefly Neuroscience that utilizes artificial intelligence and a proprietary database to analyze electroencephalogram (EEG) data. The technology compares patients’ EEG readings at rest and during activity to normative data, identifying unique brain patterns and deviations to assist in brain health evaluation and clinical decision making.
Most neurological disorders affect the neurophysiological state of brain networks. BNA™ technology can detect these subtle changes, aiding the management of various cognitive and neurological disorders, including ADHD, depression, Alzheimer’s disease, and brain injuries. While it offers significant benefits in these areas, BNA™ is most effective when integrated into a comprehensive diagnostic and treatment approach.
Yes, BNA™ is entirely non-invasive and FDA-cleared, adhering to strict safety standards. It utilizes standard EEG equipment and has undergone rigorous testing to ensure its efficacy and safety for patients of all ages.
We’re always looking for talented individuals to join our team. Explore our Careers page to view current job openings and learn more about what it’s like to work at Firefly Neuroscience.
